Stock A246720 ASTA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials ASTA Corporation

Equities

A246720

KR7246720007

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
5,950 KRW +7.40% Intraday chart for ASTA Corporation +5.12% -4.03%
2023 ASTA Corporation announced that it has received KRW 1.3000101 billion in funding from North Data Co., Ltd CI
2023 ASTA Corporation announced that it expects to receive KRW 1.3000101 billion in funding from North Data Co., Ltd CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 186,170 95,994 55,805 58,267 59,588 50,842
Enterprise Value (EV) 1 181,361 76,227 54,717 57,584 54,087 48,115
P/E ratio -42.5 x -33.1 x -5.2 x -5.66 x -15.4 x -17.8 x
Yield - - - - - -
Capitalization / Revenue 180 x 55.1 x 44.6 x 46.2 x 23.2 x 15.2 x
EV / Revenue 175 x 43.8 x 43.7 x 45.6 x 21.1 x 14.4 x
EV / EBITDA -37.3 x -10.8 x -5.41 x -64.2 x -21.1 x -24.4 x
EV / FCF -34.6 x -14.6 x -7.91 x -5.13 x -208 x -35 x
FCF Yield -2.89% -6.83% -12.6% -19.5% -0.48% -2.86%
Price to Book 12.9 x 3.24 x 3.76 x 9.06 x 6.7 x 7.03 x
Nbr of stocks (in thousands) 9,403 11,483 11,483 11,493 12,665 12,904
Reference price 2 19,800 8,360 4,860 5,070 4,705 3,940
Announcement Date 3/15/18 3/20/19 3/20/20 3/22/21 3/21/22 3/22/23
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 1,034 1,742 1,251 1,262 2,564 3,345
EBITDA 1 -4,857 -7,069 -10,110 -897.1 -2,560 -1,974
EBIT 1 -5,144 -7,331 -11,009 -1,849 -3,523 -2,779
Operating Margin -497.52% -420.87% -880.09% -146.59% -137.4% -83.07%
Earnings before Tax (EBT) 1 -5,166 -3,541 -14,996 -11,057 -3,532 -2,799
Net income 1 -4,213 -2,582 -10,740 -10,296 -3,532 -2,799
Net margin -407.45% -148.22% -858.65% -816.02% -137.76% -83.68%
EPS 2 -465.7 -252.5 -935.4 -896.4 -304.7 -220.8
Free Cash Flow 1 -5,238 -5,207 -6,915 -11,230 -259.4 -1,376
FCF margin -506.56% -298.9% -552.86% -890.04% -10.12% -41.12%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/15/18 3/20/19 3/20/20 3/22/21 3/21/22 3/22/23
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 4,809 19,767 1,088 683 5,500 2,726
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -5,238 -5,207 -6,915 -11,230 -259 -1,376
ROE (net income / shareholders' equity) -55.9% -14.9% -62% -103% -46.1% -34.7%
ROA (Net income/ Total Assets) -21.1% -14.8% -21.5% -6.78% -22.7% -15.8%
Assets 1 19,920 17,430 49,976 151,927 15,529 17,723
Book Value Per Share 2 1,532 2,584 1,291 560.0 702.0 561.0
Cash Flow per Share 2 299.0 47.30 346.0 112.0 226.0 246.0
Capex 1 405 161 1,755 568 116 224
Capex / Sales 39.21% 9.22% 140.33% 44.99% 4.51% 6.69%
Announcement Date 3/15/18 3/20/19 3/20/20 3/22/21 3/21/22 3/22/23
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ASTA CORPORATION Stock ASTA Corporation
-4.03% 56.81M
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.16% 178B
MEDTRONIC PLC Stock Medtronic plc
-1.23% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.86% 67.04B
DEXCOM, INC. Stock DexCom, Inc.
-4.28% 47.23B
CENCORA, INC. Stock Cencora, Inc.
+10.32% 44.62B
HOYA CORPORATION Stock Hoya Corporation
+8.14% 42.5B
TERUMO CORPORATION Stock Terumo Corporation
+15.53% 25.22B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-5.88% 24.14B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-5.38% 23.69B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. A246720 Stock
  4. Financials ASTA Corporation